MedTrace Logo

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

NCT02300688 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-01-13

No results posted yet for this study

Summary

After administration of besifovir preparations different from each other to healthy subjects, the investigators evaluate equivalence of bioavailability of LB80331.

Conditions

Interventions

DRUG

Treatment A

administration of 1 time administration of the test drug (Treatment A)

DRUG

Treatment B

administration of 1 time administration of the reference drug (Treatment B)

Sponsors & Collaborators

  • IlDong Pharmaceutical Co Ltd

    lead INDUSTRY

Principal Investigators

  • Jeong-Ryeol Kim, Ph D. · Samsung Medical Center, Professor of department of clinical pharmacology

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-02-28
Completion
2015-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02300688 on ClinicalTrials.gov